logo
  • Home
  • News
Menu

BioNTech, Moderna Stocks Crumble As Booster Opportunity Stands On Shaky Ground

Home / Stock Analysis / BioNTech, Moderna Stocks Crumble As Booster Opportunity Stands On Shaky Ground
Article feature image

BioNTech, Moderna Stocks Crumble As Booster Opportunity Stands On Shaky Ground

17 Sep Stock Analysis

Vaccine stocks BioNTech (BNTX) and Moderna (MRNA) toppled Friday after a Food and Drug Administration panel appeared to be leaning against Covid booster shots.
XEvercore ISI analyst Umer Raffat doesn’t expect the FDA advisory committee to vote in support…

Click here to view the original article.

Tags:
Global, Investor's Business Daily
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186744718.jpeg
+

There’s Reason For Concern Over Personal Group Holdings Plc’s (LON:PGH) Massive 25% Price Jump

16 Aug Stock Analysis
1585186774276.jpeg
+

Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

15 Aug Stock Analysis

recent post

  • 1585186744718.jpeg

    There’s Reason For Concern Over Personal

    Aug 16 2025
  • og-image-news-20240226.png

    $250M in crypto perpetual futures liquidations

    Aug 16 2025
  • Arsenal-FC-net-multi-year-crypto-trading-partnership-with-Bitpanda.jpg

    Arsenal FC net multi-year crypto trading

    Aug 16 2025
  • ‘This Is My Next SHIBA’—2021 Crypto

    Aug 16 2025
  • SFC Sets Stricter Exchange Custody Rules

    Aug 16 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.